<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recent investigations revealed that sufentanil increases cerebral blood flow (CBF) and intracranial pressure (ICP) in dogs and man </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of our study was to evaluate the impact of sufentanil on cerebral blood flow velocity and ICP in neurosurgical patients </plain></SENT>
<SENT sid="2" pm="."><plain>Eight neurosurgical ICU patients with elevated ICP (&gt; 20 mmHg) were examined </plain></SENT>
<SENT sid="3" pm="."><plain>Sufentanil was given in incremental doses of 0.5, 1.0 and 2.0 micrograms kg-1 </plain></SENT>
<SENT sid="4" pm="."><plain>Cerebral blood flow velocity decreased significantly from 54 +/- 4 cm s-1 to 48 +/- 3 cm s-1 with the dose of 1.0 microgram kg-1 sufentanil and 47 +/- 3 cm s-1 with 2.0 micrograms kg-1, respectively (mean +/- <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e>) </plain></SENT>
<SENT sid="5" pm="."><plain>ICP values did not increase with any of the doses studied </plain></SENT>
<SENT sid="6" pm="."><plain>Thus, changes of mean arterial pressure which fell with 1.0 microgram kg-1 and 2.0 micrograms kg-1 reflect cerebral perfusion pressure alterations </plain></SENT>
<SENT sid="7" pm="."><plain>Although changes of cerebral blood flow velocity revealed changes in vascular tone, ICP remained unaltered </plain></SENT>
</text></document>